Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 12-2023 | 09-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,149 | 2,419 | -12,697 | 381 | N/A |
| Income taxes - deferred | 576 | N/A | 576 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,423 | N/A | 1,197 | N/A | N/A |
| Other Working Capital | 13,200 | 412 | 10,156 | 64 | 0 |
| Other Operating Activity | 5,076 | -3,432 | 769 | -493 | 0 |
| Operating Cash Flow | $126 | $-601 | $N/A | $-48 | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -1,320 | N/A | -67,320 | N/A |
| Purchase Sale Intangibles | -5,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-5,000 | $-1,320 | $N/A | $-67,320 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,665 | N/A | N/A | N/A |
| Debt Issued | 3,800 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 69,361 | N/A |
| Other Financing Activity | 1,074 | 0 | 0 | -1,704 | 0 |
| Financing Cash Flow | $4,874 | $1,665 | $N/A | $67,657 | $N/A |
| Beginning Cash Position | N/A | 289 | N/A | 0 | N/A |
| End Cash Position | 0 | 33 | N/A | 289 | N/A |
| Net Cash Flow | $0 | $-256 | $N/A | $289 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 126 | -601 | N/A | -48 | N/A |
| Free Cash Flow | 126 | -601 | 0 | -48 | 0 |